News
FDA UpdatesLaw and AdvocacyTechnology TrendsViewpointsAll News
Media
In-Depth InsightsPharmacist ViewScript-EdExpert InterviewsPharmacy PerspectivesPodcasts
Conferences
Conference CoverageConference Listing
Resources
Disease Awareness White Board VideoAmerican Pharmacists MonthSponsored ResourcesCME/CEPartners
More
Publications
Drug Topics JournalTotal Pharmacy JournalSubmission of ArticlesSupplements And Featured Publications
Events
Virtual EventsTotal Pharmacy Solutions Summit
Business
Business StrategiesPatient ServicesPharmacy InventoryLaw and RegulationsTechnology and DataAll Business News
Practice Type
Independent PharmacyChain PharmacySpecialty PharmacyHealth System PharmacyPharmacy Technicians
Total Pharmacy

Subscribe

  • News
  • Media
  • Conferences
  • Resources
  • Publications
  • Events
  • Business
  • Practice Type
  • Subscribe
  • Total Pharmacy
  • Allergy
  • Autoimmune Diseases
  • Biosimilars
  • COVID-19
  • Cannabidiol (CBD)
  • Cardiology
  • Compounding
  • Continuous Glucose Monitoring
  • Dermatology
  • Diabetes
  • Digestive Health
  • Endocrinology
  • Eye Health
  • Generics
  • HIV
  • Headache and Migraine
  • Immunization
  • Infectious Disease
  • Influenza
  • Insulin Management
  • Medical Devices
  • Mental and Behavioral Health
  • Neurology
  • OTC
  • Obesity Management
  • Oncology
  • Pain Management
    • Nonopioid Pain Management
  • Pediatrics
  • Pneumococcal
  • Public Health
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Shingles
  • Specialty Pharmacy
  • Substance Use Disorder
  • Technology and Data
  • Veterinary Pharmacy
  • Women's Health
Spotlight -
Total Pharmacy|
NCPA Annual Convention|
American Pharmacists Month|
FDA Updates|
Pneumococcal
Advertisement

Aryanna LeBron, PharmD

Advertisement

Aryanna LeBron is a 2025 PharmD candidate at the University of Connecticut School of Pharmacy, in Storrs, Connecticut.

Articles by Aryanna LeBron, PharmD

New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood Pressure

ByAryanna LeBron, PharmD,Cassandra R. Doyno, PharmD, BCPS, BCCCP
February 11th 2025

Tryvio was given FDA approval on March 19, 2024.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Drug Topics

    1

    Pneumococcal Diseases Require Constant Vaccine Development | NCPA 2025

    2

    Why Pharmacists Need to Put More Emphasis on Supplement Education | NCPA 2025

    3

    Workforce, Access Challenges Impede Patients’ Ability to Manage Migraines | NCPA 2025

    4

    The Rise in Supplement Use Calls for Pharmacist-Led Counseling, Education | NCPA 2025

    5

    American Pharmacists Month: Pharmacy Collaboration Enables Delivery of Better Patient Care

    • About
    • Advertise
    • Editorial
    • Editorial Board
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • AdvanCE
    • Total Pharmacy
    Drug Topics
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us